Modified cell vesicles trigger 'lipid counterstorm' against lung inflammation in mice

Researchers have created a treatment called SPLEV, derived from liver cell vesicles and treated with an enzyme, to combat cytokine storms in mice. This approach shows promise in suppressing severe systemic inflammation associated with respiratory diseases.